Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of chronic conditions
3.2.1.2 Growing adoption of multi-modal imaging
3.2.1.3 Increasing investments in research and development
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent government regulations
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Gap analysis
3.10 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Contrast reagents
5.3 Optical reagents
5.4 Nuclear reagents
Chapter 6 Market Estimates and Forecast, By Imaging Modality, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 MRI
6.3 Ultrasound
6.4 X-ray and CT
6.5 Optical imaging
6.6 Nuclear imaging
6.6.1 PET
6.6.2 SPECT
6.6.3 Other nuclear imaging modalities
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Clinical diagnostics
7.2.1 Oncology
7.2.2 Cardiology
7.2.3 Neurology
7.2.4 Other clinical diagnostic application
7.3 Drug discovery and development
7.4 Research and innovation
7.5 Other applications
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Diagnostic imaging centers
8.4 Research and academic institutes
8.5 Pharmaceutical and biotechnology companies
8.6 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Bayer AG
10.2 Bracco
10.3 Carl Zeiss
10.4 Cell Signaling Technology
10.5 Danaher
10.6 General Electric Company
10.7 Guerbet
10.8 Jubilant Pharmova Limited
10.9 Luminex Corporation
10.10 Nikon Corporation
10.11 Novartis AG
10.12 Olympus Corporation
10.13 Promega Corporation
10.14 Sartorius AG
10.15 Thermo Fisher Scientific Inc.
